Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,340 | 7,298 | 369 | 3,810 | 4,034 |
| Marketable Securities | 2,452 | 175 | 3,000 | 3,550 | N/A |
| Receivables | 146 | N/A | N/A | N/A | N/A |
| Other current assets | 28 | 0 | 0 | 0 | 0 |
| TOTAL | $15,672 | $7,794 | $3,736 | $8,077 | $4,517 |
| Non-Current Assets | |||||
| PPE Net | 124 | 169 | 92 | 103 | 150 |
| Intangibles | 0 | 0 | 286 | 304 | 322 |
| Other Non-Current Assets | 421 | 2,026 | 0 | 0 | 0 |
| TOTAL | $544 | $2,195 | $378 | $407 | $472 |
| Total Assets | $16,216 | $9,989 | $4,114 | $8,484 | $4,989 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,821 | 786 | 359 | 607 | 575 |
| TOTAL | $1,821 | $786 | $359 | $607 | $575 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,100 | 3,326 | 0 | 0 | 0 |
| TOTAL | $4,000 | $4,301 | $1,050 | $1,125 | $1,200 |
| Total Liabilities | $5,821 | $5,087 | $1,409 | $1,732 | $1,775 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 181 | 153 | 117 | 116 | 105 |
| Common Shares | 8 | 7 | 6 | 6 | 5 |
| Retained earnings | -45,740 | -31,718 | -29,907 | -24,994 | -20,690 |
| Other shareholders' equity | -31 | -28 | -579 | -29 | -29 |
| TOTAL | $10,396 | $4,902 | $2,705 | $6,752 | $3,214 |
| Total Liabilities And Equity | $16,216 | $9,989 | $4,114 | $8,484 | $4,989 |